Overview

Bioequivalency Study of Mycophenolate Mofetil 500 mg Tablets Under Fasted Conditions

Status:
Completed
Trial end date:
2006-01-01
Target enrollment:
Participant gender:
Summary
The objective of this study was to prove the bioequivalence of Mycophenolate Mofetil 500 mg tablets under fasted conditions.
Phase:
N/A
Details
Lead Sponsor:
Roxane Laboratories
Treatments:
Mycophenolate mofetil
Mycophenolic Acid